HOFFMAN ESTATES, Ill., Dec. 8, 2010 /PRNewswire/ — Life Spine
announced today that the company has successfully completed initial
cases with the OCTAVE Posterior Fusion System, which is intended
for attachment to the spinous processes for the purpose of
achieving fusion in conjunction with bone graft. The U.S. Food and
Drug Administration (FDA) provided 510(k) marketing clearance to
the OCTAVE System last month.
The unique implant core design maximizes graft containment
volume while the aggressive fixation spikes allow for increased
stability between the spinous process and the implant.
OCTAVE is the sixteenth product family brought to market to date
by Life Spine, and the response to the initial OCTAVE surgeries has
been the best in Life Spine’s history.
Life Spine is dedicated to improving the quality of life for
spinal patients by increasing procedural efficiency and efficacy
through innovative design, uncompromising quality standards, and
the most technologically advanced manufacturing platforms. Life
Spine, which is privately held, is based in Hoffman Estates,
Illinois. For more information, please visit http://www.lifespine.com.